Get started
Author

Brendon Fusco

Checkpoint inhibitor‐based salvage regimens prior to autologous stem cell transplant improve event‐free survival in relapsed/refractory classic Hodgkin lymphoma
2023 · Sanjal H. Desai, Michael A. Spinner, et al. · American Journal of Hematology · 33
PDF
Disinhibition-assisted long-term potentiation in the prefrontal-amygdala pathway via suppression of somatostatin-expressing interneurons
2020 · Wataru Ito, Brendon Fusco, et al. · Neurophotonics · 19
PDF
Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent era
2023 · Sanjal H. Desai, Michael A Spinner, et al. · Blood Advances · 8
PDF
Prophylactic Vancomycin in the Primary Prevention of Clostridium difficile in Allogeneic Stem Cell Transplant
2025 · Brendon Fusco, Jasmine Tomita‐Barber, et al. · Transplant Infectious Disease · 4
Outcomes of classic Hodgkin lymphoma, relapsed within one year of diagnosis, in the era of novel agents.
2022 · Sanjal Desai, Michael Alexander Spinner, et al. · Journal of Clinical Oncology · 3
Novel Salvage Regimens Lead to Better Response and Survival in Relapsed Refractory Classic Hodgkin Lymphoma after Autologous Stem Cell Transplant
2021 · Sanjal H Desai, Michael A Spinner, et al. · Blood · 3
Comparative effectiveness of denosumab versus bisphosphonates for hypercalcemia of malignancy: a real-world cohort study
2026 · Jovan Milosavljevic, Beatrice Y Wong, et al. · The Journal of Clinical Endocrinology & Metabolism · 1
Outcomes of Autologous Stem Cell Transplant in Older Adults with Relapsed/Refractory Classic Hodgkin Lymphoma
2024 · Sanjal H. Desai, Michael A Spinner, et al. · Blood · 1
Circulating tumor DNA–based genomic landscape of KRAS wild-type pancreatic adenocarcinoma.
2023 · Brendon Fusco, Jill Tsai, et al. · Journal of Clinical Oncology · 1
PDF
Supplementary material for "Comparative Effectiveness of Denosumab Versus Bisphosphonates for Hypercalcemia of Malignancy: A Real-World Cohort Study"
2026 · Milosavljevic, Jovan, Wong, Beatrice Y, et al. · Zenodo (CERN European Organization for Nuclear Research)
Efficacy of post-transplant brentuximab vedotin maintenance by pre-transplant disease status in relapsed/refractory classic Hodgkin lymphoma
2026 · Sanjal H. Desai, Susan M. Geyer, et al. · Blood Cancer Journal
PDF
Real-world impact of first immunotherapy infusion timing on outcomes in locally advanced non-small cell lung cancer.
2026 · Mumtu Lalla, Puneet Dhillon, et al. · Journal of Clinical Oncology
Impact of earlier time of first cycle immunotherapy administration on progression-free survival in real-world metastatic non–small cell lung cancer.
2026 · Brendon Fusco, Mumtu Lalla, et al. · Journal of Clinical Oncology
PDF
Investigating age of onset and prognosis of p53 mutant myeloid malignancies in African Americans.
2025 · Brendon Fusco, Madeline D'Agostino, et al. · Journal of Clinical Oncology
PDF
Checkpoint Inhibitors Based Salvage Regimens Lead to Higher Survival in Relapsed Refractory Classic Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplant
2023 · Sanjal H Desai, Michael A Spinner, et al. · Transplantation and Cellular Therapy
Works count: 15
Citation count: 73
H-index: 4
I10-index: 2
Year
Topic
Type